Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …
reductase, has proven beneficial preventive effects on cardiovascular events. However …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach, CR Sirtori… - Cardiovascular …, 2022 - academic.oup.com
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …
reductase, has proven beneficial preventive effects on cardiovascular events. However …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications.
M Ruscica, N Ferri, M Banach, CR Sirtori… - Cardiovascular …, 2023 - europepmc.org
Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, has
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach… - Cardiovascular …, 2022 - publicum.umed.lodz.pl
Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, has proven
beneficial preventive effects on cardiovascular events. However, discontinuation due to …
beneficial preventive effects on cardiovascular events. However, discontinuation due to …
Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach, CR Sirtori… - CARDIOVASCULAR …, 2022 - air.unimi.it
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, has
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach, CR Sirtori… - Cardiovascular …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Treatment with statins, inhibitors of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase, has proven beneficial preventive effects on …
methylglutaryl-coenzyme A reductase, has proven beneficial preventive effects on …
Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach, CR Sirtori… - CARDIOVASCULAR …, 2022 - research.unipd.it
Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, has
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
M Ruscica, N Ferri, M Banach… - Cardiovascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, has
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
proven beneficial preventive effects on cardiovascular events. However, discontinuation due …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications.
M Ruscica, N Ferri, M Banach… - Cardiovascular …, 2022 - search.ebscohost.com
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …
reductase, has proven beneficial preventive effects on cardiovascular events. However …